Ignite Creation Date:
2024-05-06 @ 6:55 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05830084
Status:
RECRUITING
Last Update Posted:
2023-05-11
First Post:
2023-04-13
Brief Title:
Phase Ib Regorafenib With Conventional ChemotherapyNewly Diagnosed Patients Multimetastatic Ewing Sarcoma
Sponsor:
Gustave Roussy Cancer Campus Grand Paris
Organization:
Gustave Roussy Cancer Campus Grand Paris
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-27
Start Date Type:
ACTUAL
Primary Completion Date:
2026-03-27
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03-27
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-13
First Submit QC Date:
April 13 2023
Study First Post Date:
2023-04-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-10
Last Update Post Date:
2023-05-11
Last Update Post Date Type:
ACTUAL